European Pharmaceutical Review

JUNE 1, 2023

An oral treatment for preventing migraines has been recommended by the National Institute for Health and Care Excellence (NICE) for the first time. Rimegepant (Vydura) is recommended as an option for episodic migraine in adults after having at least three previous failed preventive treatments. How does the oral migraine treatment work?

Side effects 83

Side effects Medicine Medical Pharmaceutical 83

Legacy MEDSearch

OCTOBER 25, 2023

Theranica , a neuromodulation therapeutics company, announced the publication of a comprehensive clinical study in Advances in Therapy examining the long-term utilization, clinical efficacy, and safety of Nerivio ® , a Remote Electrical Neuromodulation (REN) device for the treatment of migraine.

Side effects 52

Side effects Recruitment Networking Management 52

Pharmaceutical Technology

OCTOBER 4, 2022

A CGRP receptor antagonist, NURTEC ODT is approved by the US Food and Drug Administration (FDA) for use in adults for acute treatment of migraine irrespective of aura status as well as for preventive episodic migraine treatment. It is also approved in the EU under the trade name Vydura for use in similar indications.

Biopharma 106

Biopharma Food and Drug Administration Medicine FDA 106

Pharmaceutical Technology

MAY 19, 2023

The US Food and Drug Administration (FDA) has accepted Satsuma Pharmaceuticals’ 505(b)(2) new drug application (NDA) for STS101 for acute treatment of migraine, for review. It provides significant benefits compared to the current acute treatments for migraine.

Food and Drug Administration 59

Food and Drug Administration FDA Prescription Food 59

Pharmacy Times

JUNE 30, 2023

Galcanezumab-gnlm (Emgality; Eli Lilly and Company) did not demonstrate superiority to rimegepant orally disintegrating tablet (Nurtec ODT) on the percentage of individuals achieving a 50% or greater reduction in monthly migraine headache days.

Safety 48

Safety 48

Pharmaceutical Technology

NOVEMBER 18, 2023

LuAG-09222 is under clinical development by H. Lundbeck and currently in Phase II for Migraine.

52

52

Pharmaceutical Technology

FEBRUARY 8, 2024

Prabotulinumtoxin A biosimilar is under clinical development by AEON Biopharma and currently in Phase II for Migraine.

Biopharma 40

Biopharma 40

Pharmaceutical Technology

JULY 19, 2022

AbbVie has filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for its atogepant for prophylaxis of migraine in adults who experience a minimum of four migraine days each month. An oral CGRP receptor antagonist (gepant), atogepant is developed as a preventive migraine treatment.

Marketing 52

Marketing Food and Drug Administration Safety Food 52

Pharmacy Times

JANUARY 4, 2023

There is a growing body of evidence that foods, substances, and additives in vitamins and supplements can be a trigger for migraine headaches.

Food 29

Food 29

pharmaphorum

JULY 18, 2022

AbbVie has submitted its oral CGRP inhibitor atogepant for prevention of both episodic and chronic migraine in the EU as it tries to catch up with main rivals Pfizer/BioHaven and their recently-approved Vydura drug. GlobalData has said it expects Qulipta to get approval for chronic migraine prevention in 2023, helping it to sales of $1.2

Sales 52

Sales Marketing Patients FDA 52

PM360

AUGUST 9, 2022

Following the annual American Society of Clinical Oncology (ASCO) conference, oncologists were asked how the data presented would impact their care of patients. When asked about driving diversity in clinical trials, 31% of surveyed oncologists felt the best solution is to create a network of clinical trial sites in underserved communities.

Healthcare 52

Healthcare Healthcare Food and Drug Administration FDA 52

Pharmacy Times

DECEMBER 7, 2023

Amanda Hickman, PharmD, MPH, MSCS, discusses the clinical assessment to lower migraines (CALM) in an HSSP setting.

Management 26

Management Patients 26

Clarivate

OCTOBER 31, 2023

billion spend on Biohaven , for example, has brought in a migraine franchise to the pharma major that had Comirnaty cash burning multiple holes in its pockets. That deal brings in a CGRP drug franchise, including the approved therapy Nurtec ODT, the only oral CGRP drug approved to prevent and treat migraines. Pfizer’s $11.6

Pharma 52

Pharma Biopharma Marketing Healthcare 52

Pharmaceutical Technology

JUNE 10, 2023

RT-002 is under clinical development by Revance Therapeutics and currently in Phase II for Upper Limb Muscle Spasticity. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. It is administered by intramuscular route and a unspecified indication.

Manufacturing 52

Manufacturing Leads Marketing Patients 52

Pharmaceutical Technology

JUNE 10, 2023

RT-002 is under clinical development by Revance Therapeutics and currently in Phase II for Upper Limb Muscle Spasticity. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. It is administered by intramuscular route and a unspecified indication.

Manufacturing 52

Manufacturing Leads Marketing Patients 52

European Pharmaceutical Review

JULY 18, 2022

Nebido is typically administered by a physician every 10-14 weeks for treatment of male hypogonadism or testosterone deficiency, It can also be used to treat clinical symptoms such as regression of secondary sexual characteristics, change in body composition, asthenia, reduced libido or erectile dysfunction.

Medicine 83

Medicine Physicians Competition Patients 83

European Pharmaceutical Review

JANUARY 11, 2024

To overcome these challenges, there have been efforts in creating more accurate bedside testing, such as eg, Quantitative Sensory Testing, and more emphasis is put on early clinical translational studies. What is the present clinical landscape for pain management medicines, especially chronic pain? References Cruccu G, Truini A.

Medicine 80

Medicine Pharmacology Management Side effects 80

pharmaphorum

NOVEMBER 11, 2022

The lack of diversity in clinical trials has been a topic of debate for decades, but was thrust into the spotlight as the impact of the pandemic on poorer, less educated and ethnically diverse populations became even more apparent. The post IQVIA’s report card for clinical trial diversity: must do better appeared first on.

Recruitment 73

Recruitment Pharma Education FDA 73

Pharmaceutical Technology

NOVEMBER 29, 2022

Researchers are also interested in ketamine’s role for the treatment of migraines. Citing his clinical experience, Dr. Eric Schwenk, professor of anesthesiology and orthopedic surgery at Thomas Jefferson University in Philadelphia, says that there are many people with migraine who would benefit from ketamine.

Side effects 110

Side effects Pharmaceutical Patients Medicine 110

European Pharmaceutical Review

JULY 13, 2023

1 Europe, however, is well placed to become a leader in driving the clinical translation of medications that display significant promise in laboratory-based studies. Cannabis complications There are notable complexities to researching medical cannabis using a linear approach to clinical translation.

Medical 87

Medical Food and Drug Administration Pharmacology Medicine 87

Pharmaceutical Technology

FEBRUARY 27, 2023

Hydrocortisone is under clinical development by Antares Pharma and currently in Phase I for Adrenal Insufficiency. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. It also develops products to reduce the risk of preterm birth in pregnant women.

Pharma 40

Pharma Pharmaceutical Pharmaceutical products Manufacturing 40

pharmaphorum

AUGUST 8, 2022

Meanwhile, bluebird bio’s one-time gene therapy lovotibeglogene autotemcel is supposed to be heading for regulatory filing in the US next year, although it has been delayed by an FDA partial clinical hold implemented after a persistent case of anaemia was seen in one adolescent patient in a clinical trial.

Marketing 100

Marketing Sales Pharma FDA 100

Pharmaceutical Technology

JULY 20, 2022

Prescribing it] requires knowledge of a patient’s medical history, as well as clinical monitoring for side effects and follow-up care to determine whether a patient is improving—requirements far beyond a pharmacist’s scope and training,” as per a statement by AMA president Jack Resneck.

Food and Drug Administration 111

Food and Drug Administration Physicians Prescription Medical 111

pharmaphorum

NOVEMBER 15, 2022

Among those who partook in the survey, the most diagnosed chronic conditions they suffered from were anxiety (56%) and depression (52%), and chronic pain (26%), hypertension (24%), and migraine (22%). Of those who were afflicted by anxiety, 73% also battled with depression.

Education 117

Education Healthcare Provider Physicians Electronics 117

Pharmaceutical Technology

FEBRUARY 20, 2023

According to Globaldata, it is involved in 17 clinical trials, of which 11 were completed, and 6 were terminated. The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. S,S-Reboxetine is administered through oral route.

Transportation 40

Transportation Sales Leads Pharmaceutical 40

pharmaphorum

AUGUST 21, 2022

There’s no word yet on its pricing, but for comparison Spravato was launched with an annual price tag of around $32,400, which the Institute for Clinical and Economic Review (ICER) concluded was around 25% to 52% too high to be cost effective.

FDA 87

FDA Marketing Pharma Sales 87

Clarivate

APRIL 18, 2024

As Amazon taps technology to rewire healthcare and medicine delivery, employee-owned supermarket chain Hy-Vee is launching new programs that draw consumers to its robust retail health and pharmacy business, which includes a fleet of mobile health units and numerous healthcare clinics operated by provider partners, among other services.

Retail 52

Retail Healthcare Healthcare Physicians 52

pharmaphorum

NOVEMBER 2, 2022

One company that is applying digital therapeutics to chronic pain is Jogo Health, which has developed solutions for pelvic pain, migraine/tension type headache, and chronic lower back pain. Digital therapeutics can also provide patients with education on their condition and help to maintain motivation to stick with treatment plans.

Food and Drug Administration 126

Food and Drug Administration Food FDA Patients 126

PM360

JUNE 29, 2022

The migraine therapy market has heated up over the past few years with the emergence of many new acute and preventive medications. Only about half of those living with migraine (52%) have tried acute therapy, and just 37% have investigated preventive therapy, the survey found. Migraine Is Widespread, But Expertise Is Limited.

Prescription 98

Prescription Patients Pharma Doctors 98

Clarivate

APRIL 6, 2022

Pre-publication peer review: Can Ciprofloxacin be Used for Precision Treatment of Gonorrhea in Public STD Clinics? Post-publication peer review: Brain state monitoring for the future prediction of migraine attacks. Pre-publication peer review: Patterns and mechanisms in instances of endosymbiont-induced parthenogenesis.

Training 98

Training Ethics Networking Government 98

Pharma Marketing Network

JUNE 10, 2020

And it’s the first time I’m seeing our friends on the clinical side of the business out innovating the commercial side of the business in pharma. Novartis, Boehringer, Pfizer are all on the clinical side really chasing the innovations around R&D. Now to get somebody into a clinical trial.

Pharma 52

Pharma Marketing Doctors Recruitment 52

Pharma Marketing Network

JUNE 10, 2020

And it’s the first time I’m seeing our friends on the clinical side of the business out innovating the commercial side of the business in pharma. Novartis, Boehringer, Pfizer are all on the clinical side really chasing the innovations around R&D. Now to get somebody into a clinical trial.

Pharma 40

Pharma Marketing Doctors Recruitment 40

European Pharmaceutical Review

SEPTEMBER 7, 2022

These newly developed tools can be used in clinical research, for instance drug absorption studies, and can contribute to faster and more efficient development of oral pharmaceutical products. For example, capsules have been created that allow for monitoring of external conditions, such as pH, and external control over drug release.

Pharmaceutical 121

Pharmaceutical Pharma Manufacturing Patients 121

Celeritas

FEBRUARY 20, 2023

Whether setting up a clinic, refreshing your practice, or adding new wings or care outlets, this article will be your guide to organizing your inventory in an efficient and intuitive manner. The variety and complexity of inventory will vary from small, privately owned clinic to vast veterinary hospital chains.

Management 52

Management Retail Medical Sales 52

Medico Reach

MAY 10, 2022

The company is known for revolutionary clinical trials and biotechnology research. The key products in their catalog include Aimovig for treating migraine and Corlanor for addressing chronic heart failure. Invention Ranking : 1. Innovation ranking : 2 . Industry revenue : $81.3 CEO : Albert Bourla.

Pharmaceutical 52

Pharmaceutical Medicine Medical science FDA 52

pharmaphorum

JUNE 29, 2022

Kirstie has over 5 years’ experience in healthcare and life sciences, previously working to provide industry expertise and analytics which support industry associations to influence health policy, and providing clinical and commercial competitive insights for pharmaceutical companies.

Doctors 59

Doctors Medicine Marketing Prescription 59

Pharmaceutical Technology

MAY 10, 2023

On May 9, The Scottish Medicines Consortium approved the inclusion of Pfizer and Biohaven’s Vydura (rimegepant) into the Scottish National Health Services (NHS) for the acute treatment of migraines. However, the regulator did not grant the drug approval for its use in preventing migraines.

Medicine 52

Medicine Prospecting Medical Competition 52